178 related articles for article (PubMed ID: 1965793)
21. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia.
Yin JA; Jowitt SN
Bone Marrow Transplant; 1992 Jan; 9(1):31-3. PubMed ID: 1543947
[TBL] [Abstract][Full Text] [Related]
22. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
23. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
24. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
[TBL] [Abstract][Full Text] [Related]
25. Disappearance of lupus anticoagulant after allogeneic bone marrow transplantation.
Olalla JI; Ortín M; Hermida G; Baro J; Sedano C; Morante C; Zubizarreta A
Bone Marrow Transplant; 1999 Jan; 23(1):83-5. PubMed ID: 10037055
[TBL] [Abstract][Full Text] [Related]
26. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation.
Fouillard L; Deconinck E; Tiberghien P; Deschaseaux ML; Solary E; Mugneret F; Brion A; Herve P; Cahn JY
Bone Marrow Transplant; 1998 May; 21(9):943-6. PubMed ID: 9613789
[TBL] [Abstract][Full Text] [Related]
27. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
29. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
30. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
[TBL] [Abstract][Full Text] [Related]
31. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
[TBL] [Abstract][Full Text] [Related]
32. [Bone marrow transplantation in children].
Poros A
Orv Hetil; 1993 Jun; 134(25):1387. PubMed ID: 8332358
[No Abstract] [Full Text] [Related]
33. Plasmodium vivax causing pancytopenia after allogeneic blood stem cell transplantation in CML.
Raina V; Sharma A; Gujral S; Kumar R
Bone Marrow Transplant; 1998 Jul; 22(2):205-6. PubMed ID: 9707032
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation at The Mount Sinai Hospital.
Fruchtman SM; Scigliano E; Ross V; Abramowitz A; Lipton J; Mandell L; Shank B
Mt Sinai J Med; 1994 Jan; 61(1):3-12. PubMed ID: 8183289
[No Abstract] [Full Text] [Related]
35. Peripheral neuropathy following high-dose etoposide and autologous bone marrow transplantation.
Imrie KR; Couture F; Turner CC; Sutcliffe SB; Keating A
Bone Marrow Transplant; 1994 Jan; 13(1):77-9. PubMed ID: 8019457
[TBL] [Abstract][Full Text] [Related]
36. Linear IgA dermatosis in an immunosuppressed patient after allogenic bone marrow transplantation.
Schultewolter T; Goos M; Dissemond J
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):721-5. PubMed ID: 15482308
[TBL] [Abstract][Full Text] [Related]
37. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
Gale RP; Horowitz MM
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
[TBL] [Abstract][Full Text] [Related]
38. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
[TBL] [Abstract][Full Text] [Related]
39. Fatal immune-mediated pancytopenia and a TRALI-like syndrome associated with high titers of recipient-type antibodies against donor-derived peripheral blood cells after allogeneic bone marrow transplantation following dose reduced conditioning.
Knop S; Bux J; Kroeber SM; Bader P; Hebart H; Kanz L; Einsele H
Haematologica; 2004 May; 89(5):ECR12. PubMed ID: 15136241
[TBL] [Abstract][Full Text] [Related]
40. High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.
Schneider EM; Dörries K
Transplant Proc; 1993 Feb; 25(1 Pt 2):1271-3. PubMed ID: 8382856
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
